Topotecan Active Not Recruiting Phase 2 / 3 Trials for Lung Cancer Small Cell Lung Cancer (SCLC) Treatment

IndicationsStatusPurposePhase
Active Not RecruitingTreatment2 / 3
clinicaltrials.gov IdentifierTitleDrugs
NCT02963090Pembrolizumab vs Topotecan in Patients With Small Cell Lung Cancer